FDA may form new group for MQSA

Article

The Food and Drug Administration may soon have a dedicated divisionto implement the Mammography Quality Standards Act of 1992 ifa proposal by the Center for Devices and Radiological Health isapproved by the agency. Tentatively called the Division of

The Food and Drug Administration may soon have a dedicated divisionto implement the Mammography Quality Standards Act of 1992 ifa proposal by the Center for Devices and Radiological Health isapproved by the agency.

Tentatively called the Division of Mammography Quality andRadiation Programs, the organization will be located under theOffice of Training and Assistance, according to Richard Gross,assistant director for liaison at the OTA.

"It's informal until all of the paperwork gets handled,"he said. "But that's the direction the Center director (Dr.Bruce Burlington) is going to recommend."

Although the responsibilities for the new division are stillbeing discussed, the unit will take over radiation programs previouslyhandled by the former Division of Technical Development. The mostvisible of these programs is the Nationwide Evaluation of X-rayTrends, a cooperative program with the Conference of RadiationControl Program Directors, Gross said.

The reorganization of the OTA has been talked about for overa year, Gross said.

"When the responsibilities of the MQSA were assigned tothis office, it was another impetus for restructuring and tryingto figure out a new approach to things," he said.

A dedicated division will aid the FDA in developing its programfor implementing MQSA, Gross said.

"You have to have a consistent, centralized organizationto get (the program) developed," he said. "A lot ofdevelopmental activities are required. The primary function inthe beginning will be to develop standards."

Under MQSA, every mammography unit in the U.S. will have tobe certified by Oct. 1, 1994, or cease operations.

The division's interim director is Joseph S. Arcarese. Becausehe is retiring on Nov. 1, a recruiting announcement for a permanentdirector has been released, Gross said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.